Hotel Dieu

Nantes, Loire-Atlantique 44093

0 studies enrolling now · 3 studies all time

What they study most

Acute Antibody-Mediated Rejection (AMR), Multiple Myeloma, Relapsed or Refractory Systemic Light Chain Amyloidosis

Studies at this site

• Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis — Stopped early
• A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT) — Completed
• A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant — Stopped early